Difference between revisions of "Part:BBa K3771080"
 
(5 intermediate revisions by 2 users not shown)
Line 5: Line 5:
 
<html>
 
<html>
 
<br><b style="font-size:1.3rem">Description</b>
 
<br><b style="font-size:1.3rem">Description</b>
−
<br>
 
  
 
<br><i>P<sub>T7</sub>-coaBC</i> is a composite part consisting of the <i>T7</i> promoter and the <i>coaBC</i> sequences. This part was used in <i>in vivo</i> testing of taurine production. The sequence for <i>jju</i> and <i>coaBC</i> promoter were ligated and transformed into <i>E. coli</i> to calculate taurine production using high-performance liquid chromatography (HPLC).
 
<br><i>P<sub>T7</sub>-coaBC</i> is a composite part consisting of the <i>T7</i> promoter and the <i>coaBC</i> sequences. This part was used in <i>in vivo</i> testing of taurine production. The sequence for <i>jju</i> and <i>coaBC</i> promoter were ligated and transformed into <i>E. coli</i> to calculate taurine production using high-performance liquid chromatography (HPLC).
Line 11: Line 10:
  
 
<br><b style="font-size:1.3rem">Biology</b>
 
<br><b style="font-size:1.3rem">Biology</b>
−
<br>
 
  
 
<br><i>T7</i> promoter constitutively facilitates the expression of CoaBC enzyme.
 
<br><i>T7</i> promoter constitutively facilitates the expression of CoaBC enzyme.
 +
 
<br>
 
<br>
  
 
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
−
<img src="https://2021.igem.org/wiki/images/c/c9/T--NCKU_Tainan--taurine_pathway_1.png" style="width:50%;">
+
<img src="https://2021.igem.org/wiki/images/c/c9/T--NCKU_Tainan--taurine_pathway_1.png" style="width:35%;">
 
</div>
 
</div>
−
<p align="center">圖片描述</p>
+
  <p align="center">Fig. 1. Taurine pathways in <i>E. coli</i>
 +
  </p>
 +
 
 +
 
 +
 
 +
<br><b style="font-size:1.3rem">Usage</b>
 +
<br>
 +
 
 +
  <br>CoaBC enzyme was used <i>in vitro</i> testing of taurine production. The sequence for CoaBC enzyme and <i>trc</i> promoter were ligated and transformed into <i>E. coli</i> to calculate taurine production using high-performance liquid chromatography (HPLC).
 +
<br> 
 +
 
 +
 
 +
 
 +
 
 +
<br><b style="font-size:1.3rem">Characterization</b>
 +
<br>
  
 
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 
<img src="https://2021.igem.org/wiki/images/7/7f/T--NCKU_Tainan--CoaBC-PCR.png" style="width:35%;">
 
<img src="https://2021.igem.org/wiki/images/7/7f/T--NCKU_Tainan--CoaBC-PCR.png" style="width:35%;">
 
</div>
 
</div>
−
<p align="center">Fig. 1 Confirmation of coaBC fragment by PCR. M: Marker; Lane 1: coaBC (1221 bp)</p>
+
  <p align="center">Fig. 2. Confirmation of <i>coaBC</i> fragment by PCR. M: Marker; Lane 1: <i>coaBC</i> (1221 bp)</p>
  
 
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 
<img src="https://2021.igem.org/wiki/images/5/53/T--NCKU_Tainan--CoaBC-plate%28DH5a%29.png" style="width:35%;">
 
<img src="https://2021.igem.org/wiki/images/5/53/T--NCKU_Tainan--CoaBC-plate%28DH5a%29.png" style="width:35%;">
 
</div>
 
</div>
−
<p align="center">Fig. 2 Transformation/CoaBC in DH5α</p>
+
<p align="center">Fig. 3. Transformation/CoaBC in DH5α</p>
  
 
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 
<img src="https://2021.igem.org/wiki/images/5/59/T--NCKU_Tainan--CoaBC-digestion.png" style="width:35%;">
 
<img src="https://2021.igem.org/wiki/images/5/59/T--NCKU_Tainan--CoaBC-digestion.png" style="width:35%;">
 
</div>
 
</div>
−
<p align="center">Fig. 3 Confirmation of  pET28a-T7-CoaBC by digestion.
+
  <p align="center">Fig. 4. Confirmation of  pET28a-<i>P<sub>T7</sub>-coaBC</i> by digestion.
−
M: Marker; Lane 1~3: Different colonies of pET28a-T7-CoaBC (5398 bp)
+
M: Marker; Lane 1~3: Different colonies of pET28a-<i>P<sub>T7</sub>-coaBC</i> (5398 bp)
 
</p>
 
</p>
  
Line 41: Line 55:
 
<img src="https://2021.igem.org/wiki/images/d/d1/T--NCKU_Tainan--CoaBC-plate%28BL21%28DE3%29%29.png" style="width:35%;">
 
<img src="https://2021.igem.org/wiki/images/d/d1/T--NCKU_Tainan--CoaBC-plate%28BL21%28DE3%29%29.png" style="width:35%;">
 
</div>
 
</div>
−
<p align="center">Fig. 4 Transform into BL21(DE3)</p>
+
<p align="center">Fig. 5. Transform into BL21(DE3)</p>
  
 
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 
<div style="width=100%; display:flex; align-items: center; justify-content: center;">
 
<img src="https://2021.igem.org/wiki/images/3/39/T--NCKU_Tainan--CoaBC-PAGE.png" style="width:35%;">
 
<img src="https://2021.igem.org/wiki/images/3/39/T--NCKU_Tainan--CoaBC-PAGE.png" style="width:35%;">
 
</div>
 
</div>
−
<p align="center">Fig. 5 Confirmation of protein expression of CoaBC.
+
<p align="center">Fig. 6. Confirmation of protein expression of CoaBC.
 
M: Marker; Lane1: whole cell of CoaBC in BL21(DE3); Lane2: soluble protein of CoaBC in BL21(DE3) (~45 kDa)
 
M: Marker; Lane1: whole cell of CoaBC in BL21(DE3); Lane2: soluble protein of CoaBC in BL21(DE3) (~45 kDa)
 
</p>
 
</p>
 +
 
 +
 
 +
 
 +
<br><b style="font-size:1.3rem">References</b>
 +
<br>BRENDA - Information on EC 4.4.1.10 - cysteine lyase. Brenda-enzymes.org. Published 2021. Accessed October 6, 2021. https://www.brenda-enzymes.org/enzyme.php?ecno=4.4.1.10<br>
  
−
<br><b style="font-size:1.3rem">Usage</b>
 
−
<br>
 
−
 
−
<br><b style="font-size:1.3rem">Characterization</b>
 
−
<br>
 
−
 
−
<br><b style="font-size:1.3rem">References</b>
 
−
<br>
 
 
</html>
 
</html>
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Latest revision as of 02:58, 22 October 2021


T7-CoaBC


Description
PT7-coaBC is a composite part consisting of the T7 promoter and the coaBC sequences. This part was used in in vivo testing of taurine production. The sequence for jju and coaBC promoter were ligated and transformed into E. coli to calculate taurine production using high-performance liquid chromatography (HPLC).

Biology
T7 promoter constitutively facilitates the expression of CoaBC enzyme.

Fig. 1. Taurine pathways in E. coli


Usage

CoaBC enzyme was used in vitro testing of taurine production. The sequence for CoaBC enzyme and trc promoter were ligated and transformed into E. coli to calculate taurine production using high-performance liquid chromatography (HPLC).

Characterization

Fig. 2. Confirmation of coaBC fragment by PCR. M: Marker; Lane 1: coaBC (1221 bp)

Fig. 3. Transformation/CoaBC in DH5α

Fig. 4. Confirmation of pET28a-PT7-coaBC by digestion. M: Marker; Lane 1~3: Different colonies of pET28a-PT7-coaBC (5398 bp)

Fig. 5. Transform into BL21(DE3)

Fig. 6. Confirmation of protein expression of CoaBC. M: Marker; Lane1: whole cell of CoaBC in BL21(DE3); Lane2: soluble protein of CoaBC in BL21(DE3) (~45 kDa)


References
BRENDA - Information on EC 4.4.1.10 - cysteine lyase. Brenda-enzymes.org. Published 2021. Accessed October 6, 2021. https://www.brenda-enzymes.org/enzyme.php?ecno=4.4.1.10
Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 632
  • 1000
    COMPATIBLE WITH RFC[1000]